Holocene Advisors, LP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1700574 New York, NY

Position in HIMS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,106,692

+$11,625,930 QoQ

Shares Held

583,174

+1103.3% QoQ

Ownership

0.252%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Holocene Advisors, LP holds $100,418,965 across 4 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	2,317,326	$81,940,647
2	HIMS	Hims & Hers Health, Inc. This page	583,174	$12,106,692
3	TEVA	Teva Pharmaceutical Industries Ltd	180,849	$5,447,171
4	UTHR	UNITED THERAPEUTICS Corp	1,559	$924,455

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,106,692	583,174	+1103.3%	Shares	Sole	2026-05-15
2023-03-31	$480,762	48,464	+103.9%	Shares	Sole	2023-05-15
2022-03-31	$126,662	23,764	-92.2%	Shares	Sole	2022-05-16
2021-12-31	$2,007,575	306,500	+18.2%	Shares	Sole	2022-02-14
2021-09-30	$1,954,503	259,218	+554.9%	Shares	Sole	2021-11-15
2021-06-30	$431,058	39,583	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.